(2020) , and Mitjà et al., 2020) provided no information on baseline disease severity, although it may not be significant for the trials by Esper et al.
← all excerpts
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
1
—
—